ReproCELL Incorporated
株式会社リプロセル
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4978
FY2025 (Mar 2026) · J-GAAP · consolidated Source: filing S100YLVF
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
| Gross margin | 45.5% |
|---|---|
| Operating margin | -38.5% |
| Net margin | -26.5% |
| Return on equity | -6.6%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | -6.1% |
| Revenue growth (YoY) | -25.0% |
| EPS (basic) | −¥6.25 |
| EPS growth (YoY) | -663.1% |
| Current ratio | 11.87x |
| Equity ratio | 91.7% |
| Book value / share | ¥93.09 |
| Free cash flow | −¥482M |